Phase II Single Arm Study of Combination Pembrolizumab, Paclitaxel, and Carboplatin in Patients With Advanced Stage Ovarian, Fallopian Tube, or Peritoneal Carcinoma Receiving Neoadjuvant Chemotherapy
Phase of Trial: Phase II
Latest Information Update: 08 Apr 2017
At a glance
- Drugs Pembrolizumab (Primary) ; Carboplatin; Paclitaxel
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 02 Mar 2017 Planned primary completion date changed from 1 Dec 2021 to 1 Dec 2020.
- 15 Dec 2016 Planned primary completion date changed from 1 Dec 2020 to 1 Dec 2021.
- 15 Dec 2016 Status changed from not yet recruiting to recruiting.